MUC1 and breast cancer: Maeda et al. showed that in triple-negative BC, MUC1-C upregulation recruits MYC and NF-κB p65 to the PD-L1 promoter, enhancing PD-L1 expression and leading to immune escape and reduced patient survival [67].